CEBPA and acute myeloid leukemia: Furthermore, TRIB2 binds to and facilitates the degradation of CCAAT/enhancer-binding protein alpha (C/EBP-α) in a process proposed to be a key feature of TRIB2-induced acute myelogenous leukemia [15].